What question did this study set out to answer?

This research examines the effectiveness of extracorporeal shock wave therapy (ESWT) in treating post-stroke spasticity and investigates the dose-response relationship.

February 14, 2026Open Access

Efficacy of extracorporeal shock wave therapy for post-stroke spasticity and dose-response analysis: a meta-analysis of randomized controlled trials

Key Points

This research examines the effectiveness of extracorporeal shock wave therapy (ESWT) in treating post-stroke spasticity and investigates the dose-response relationship.
Conducted a meta-analysis of randomized controlled trials (RCTs)
Evaluated both short- and long-term effects of ESWT on post-stroke spasticity
Analyzed heterogeneity in treatment responses across studies
ESWT significantly reduces post-stroke spasticity (PSS)
A dose-response relationship indicates that higher doses yield better outcomes
Evidence of both immediate and longer-term benefits from treatment

Abstract

ESWT effectively reduces PSS with short- and long-term benefits. A dose-response relationship suggests higher doses provide better outcomes. However, further research is needed to optimize treatment protocols due to the observed heterogeneity.

Efficacy of extracorporeal shock wave therapy for post-stroke spasticity and dose-response analysis: a meta-analysis of randomized controlled trials

Key Points

Abstract

Cite This Study